Noelle K. Eder - 07 Mar 2025 Form 4 Insider Report for Cigna Group (CI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Mar 2025, 17:11:49 UTC
Prior SEC filing
04 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Matthew Arnold, attorney-in-fact

Key filing fact

Noelle K. Eder filed Form 4 for Cigna Group (CI) on 11 Mar 2025.

Key facts

  • This page summarizes Noelle K. Eder's Form 4 filing for Cigna Group (CI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 11 Mar 2025, 17:11.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: -$3,182,080.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$3,182,080
Shares
-9,944
Change %
-43%
Price
$320.00
Shares after
13,406
Date
07 Mar 2025
Ownership
Direct
Footnotes
F1
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
184
Date
07 Mar 2025
Ownership
By 401(k)
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.

Footnote F2

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

SEC remarks

EVP, Global Chief Information Officer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .